Latest News
Lawyers from Carey Olsen have advised West China Cement on its offering and listing on the Hong Kong Stock Exchange, which completed on 23 August 2010.
West China Cement is a cement producer in the Shaanxi province of China.
It is the first Chinese business held through a Jersey company to list on the Hong Kong Stock Exchange.
The offering, comprising of a Hong Kong public offering and an international placing, was substantially oversubscribed and has raised approximately HKD1,280m.
Partner Guy Coltman led the team providing Jersey legal advice on the transaction.
“Carey Olsen is honoured to be part of
Investment manager Insynergy has appointed Nicola Large as commercial director.
Working closely with chief executive and founder Spike Hughes, Large will have lead responsibility for managing the investment manager’s commercial and financial affairs.
With ten years of financial services experience, she will oversee the evolution of the firm’s developing corporate structure and ensure the highest quality reporting standards.
Large joins Insynergy from emerging markets focused private equity firm Actis, where she was an analyst in the investor development group. Focusing primarily on the African private equity and global infrastructure segments of the business, her responsibilities included the analysis of investment
Harris Williams has acted as exclusive adviser to Country Pure Foods, a portfolio company of First Atlantic Capital and DN Partners, in its sale to Mistral Equity Partners.
The transaction was led by Glenn Gurtcheff, Tim Alexander, Jeffrey Cleveland and Ryan Budlong from Harris Williams’ Minneapolis office.
“Country Pure Foods has an extraordinary track record of providing premium quality juice to blue-chip customers in the institutional foodservice, retail, and co-packing markets. With the industry’s broadest product portfolio and the infrastructure required to service national foodservice accounts, the company has established a leading market position for which to continue generating profitable
Vanterra C Change Transformative Energy & Materials Fund I launched with a USD100m initial close earlier this month, led by anchor investor Vanterra Capital in partnership with C Change Investments.
The fund was founded by John T. Preston, energy investor and former director of technology development for MIT; John Sylvia, a former partner at TPG and chief operating officer of CalEnergy; Roger Berry, formerly of Climate Change Capital; and Alan Quasha and Shad Azimi (pictured), managing partners of Vanterra Capital.
The fund was established to identify proprietary investments in companies that help to transform the operations of industrial users and
American Capital has sold its portfolio company Narus to Boeing for proceeds of USD12m.
American Capital realised a gain of USD3m during the third quarter from the transaction, subject to post-closing adjustments.
American Capital’s compounded annual rate of return earned over the life of its investment was seven per cent.
The proceeds received by American Capital were less than the second quarter 2010 valuation of the investment by USD2m, or 13 per cent.
Including investments in Narus by American Capital’s affiliated funds under management, the total proceeds received during the third quarter from the transaction were USD21m, realising a gain
WinSonic Digital Media Group, a facilities-based digital media company, has completed a USD5m equity funding facility with Georgia-based Roswell Capital Partners.
Roswell has committed to purchase, over a period of two years, shares of the company’s common stock for cash consideration, up to an aggregate of USD5m.
The equity funding facility is a flexible financing instrument that places WinSonic in control of how and when it raises equity. WinSonic can privately place its common shares as strategic opportunities arise and equity financing is attractive to the company. The agreement does not prohibit the company from raising additional debt or equity
Tim Levy, chief executive of GBP6bn alternative investment firm Future Capital Partners, is about to embark on a expedition led by Bear Grylls through the Northwest Passage.
Future Capital’s investment partnership Future Fuels, which will fund the construction of a renewable fuel plant in the UK, is sponsoring the expedition.
The 14 day trip will raise awareness of the effect of climate change on the planet and raise money for UK charity Global Angels, providing safe drinking water for thousands of children in Africa.
The expedition through the formerly frozen Northwest Passage will begin on 28 August in Pond Inlet
Joseph F Winterscheid (pictured), partner and head of the global Antitrust & Competition Practice Group at McDermott Will & Emery, outlines the implications of the FTC’s revised Horizontal Merger Guidelines.
Last week, the Federal Trade Commission (FTC) released the final revised Horizontal Merger Guidelines that describe the FTC and U.S. Department of Justice’s (DOJ’s) methodology for analysing the likely competitive impact of mergers and acquisitions between competitors.
While the Guidelines de-emphasise the role of market definition in the FTC’s and DOJ’s analyses of transactions, they largely memorialize the agencies’ existing practices in the merger review process.
The new guidelines’ shift
Citadel Capital, a private equity firm in the Middle East and Africa, has reported a 5.3 per cent rise in total net asset value per share for the second quarter of 2010.
The portfolio net asset value rose by 1.7 per cent and the asset management value rose by 12.5 per cent.
“The second quarter of 2010 was about delivering on our promises to investors,” says chairman and founder Ahmed Heikal. “In our last business review, we pledged to fine-tune our balance sheet by recovering loans that we had extended to platform companies to bridge LP delays in answering capital
The medical devices business of Golden Meditech Holdings, a China-based healthcare enterprise, has raised USD40m from private equity investors.
The proceeds will fund the construction of new production lines for both medical devices and medical accessories to fund the formation of a joint venture with Fenwal.
The group’s interest in the medical devices business will be diluted to 74.123 per cent upon completion.
The group’s medical devices business currently consists of its medical device production operation and distribution affiliate with the former being the first and largest autologous blood recovery system manufacturer in China and the latter the largest medical
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
